-ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?
Ballow
Mark
M
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000954:Antigens, Surface / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy; D002465:Cell Movement / Q000276:immunology; D018925:Chemokines / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy; D007073:Immunoglobulin E; D007155:Immunologic Factors / Q000276:immunology; D018836:Inflammation Mediators / Q000276:immunology; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D019707:Receptors, Chemokine / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D009626:Terminology as Topic
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D018925:Chemokines; D016207:Cytokines; D000939:Epitopes; D007155:Immunologic Factors; D018836:Inflammation Mediators; D011948:Receptors, Antigen, T-Cell; D019707:Receptors, Chemokine; D007073:Immunoglobulin E